To promote research in fields in which India relies largely on technology from abroad, the country’s government will launch a funding opportunity on November 5 of INR 1,000 crore ($154 million). An interministerial group will review projects and proposals submitted by India’s research and technology institutes for the awards. The IMPRINT funding mechanism will support […]
Following up on previous programs, in August, the Chinese government announced World Class 2.0, a plan for its best universities to attain world-class status. As revealed at the Organization for Economic Co-Operation and Development’s Higher Education Futures conference earlier this month, the program has been initiated despite some budgetary limitations. Under the plan, hubs for […]
In 2014, the UK’s bioscience sector hit a financial high, raising £1.2 billion ($1.97 billion) in innovation capital, or equity capital raised by companies with annual revenues less than $500 million. This was an increase of 143% and more than one-third of the £3.9 billion in bioscience innovation capital that Europe raised that year. The […]
The Izmir Biomedicine and Genome Center (iBG), based at Dokuz Eylül University, was launched in Turkey last month. The Center is considered an opportunity to bring hope and prominence to research in the country. Turkey’s current science funding, most of which is allocated to applied research, though increasing, is less than half of the EU’s […]
This month, New Zealand’s government released the “National Statement of Science Investment (NSSI) for 2015–2025.” The strategy’s 10-year goals are a simpler, more transparent science system investing effectively in the long term to benefit the country’s health, environment and society. The NSSI seeks to elevate New Zealand’s position as an R&D destination, and to regularly […]
For the third straight year, Canada’s gross domestic expenditure on R&D (GERD) in 2015 is expected to decline, falling 0.7% to CAD 31.6 billion ($23.8 billion). This drop is predicted for spending in all performing sectors except higher education and the federal government, which are anticipated to experience 1.0% and 4.0% increases to CAD 13.0 […]
A survey by Farmaindustria found that Spain’s pharmaceutical industry spent €950 million ($1.06 billion) on R&D in 2014. This rise in investment followed three years of declines related to the economic crisis. Intramural research accounted for €568 million, or 59% of expenditures, while the remaining investment of €382 million was put toward research contracts with […]
Pharmaceutical companies in China have increased their investment in R&D to 6.9% of revenue in 2014 from 3.9% in 2009. This has helped them make the shift from manufacturers of active pharmaceutical ingredients to drug developers. Sino Biopharm, for example, stepped up its R&D investment sevenfold to $140 million from 2009 to 2014. This, along […]
This month, the main German agency for research funding, the DFG, reported results of the country’s Excellence Initiative. Begun in 2006, the program will spend €4.6 billion ($5 billion) over 11 years to strengthen prestigious German universities. From 2011 to 2013, 45 institutions received more than €1 billion to run graduate programs and establish clusters […]
The Chinese government is spending over $200 billion annually on R&D, or about 2% of GDP. But, in many ways, the funding is applied ineffectively. For example, while government incentives have prompted patent filings, when controlling for quality, patent numbers fall short of many other countries’. According to the World Bank, state-owned enterprises have shown […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
